IP Library Granted Patent US 11,566,244
Granted Patent B2
US 11,566,244 · App. 16/703,190 · Granted Jan 31, 2023

Methods for multiplexing recombinase polymerase amplification

Inventors: Olaf Piepenburg (Hertfordshire, GB); Colin H. Williams (London, GB); Niall A. Armes (Essex, GB)
Assignee: ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
C12N15/113C12Q1/6804C12Q1/6816C12Q1/6827C12Q1/6844C12Q1/6853G01N21/78G01N33/558G01N2021/7759G01N2021/7763G01N2021/7793
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,566,244
App. No.
16/703,190
Granted
Jan 31, 2023
Kind
B2
Abstract

This disclosure provides for methods and reagents for rapid multiplex RPA reactions and improved methods for detection of multiplex RPA reaction products. In addition, the disclosure provides new methods for eliminating carryover contamination between RPA processes.

Claims (28)

1. A method comprising:

providing a liquid sample comprising a target nucleic acid;

combining the liquid sample with a recombinase polymerase amplification (RPA) reagent composition to provide a reaction mixture, wherein the RPA reagent composition comprises:

a recombinase;

a polymerase;

a first nucleic acid primer;

a second nucleic acid primer;

a third extension-blocked primer comprising an elongation blocking group at a 3′ end, an internal tetrahydrofuran (THF) residue, and an internal residue non-complementary to the target nucleic acid; and

a nuclease;

performing RPA on the reaction mixture to produce an amplicon indicative of the presence of the target nucleic acid; and

detecting the presence of the amplicon using a lateral flow strip.

2. The method of claim 1 , wherein the lateral flow strip is configured to form a visible signal at a specific position on the lateral flow strip indicating the presence of the target nucleic acid.

3. The method of claim 1 , wherein the lateral flow strip comprises a sample pad, a detection line, and a control line, wherein said detection line is positioned upstream of a control line.

4. The method of claim 3 , further comprising transferring all or part of the reaction mixture to the sample pad;

flowing the reaction mixture to the detection line; and

capturing an amplicon indicating the presence of the target nucleic acid at the detection line.

5. The method of claim 1 , wherein said first nucleic acid primer is labeled with a first detectable label selected from the group consisting of enzymes, enzyme substrates, coenzymes, enzyme inhibitors, fluorescent markers, chromophores, luminescent markers, radioisotopes, and a member of a binding pair; and/or said second nucleic acid primer is labeled with a second detectable label selected from the group consisting of enzymes, enzyme substrates, coenzymes, enzyme inhibitors, fluorescent markers, chromophores, luminescent markers, radioisotopes, and a member of a binding pair.

6. The method of claim 5 , wherein an amplicon comprises the first detectable label and/or the second detectable label(s).

7. The method of claim 6 , wherein said amplicon comprising the first detectable label and/or the second detectable label(s) produces a visible signal on the lateral flow strip.

8. The method of claim 5 , wherein said first nucleic acid primer and/or said second nucleic acid primer is/are labeled with a member of a binding pair that is a biotin, an avidin, a streptavidin, an antigen, an antibody, a ligand, a receptor, an analog or a mutant of a biotin, an analog or a mutant of an avidin, an analog or a mutant of a streptavidin, an analog or a mutant of an antigen, an analog or a mutant of an antibody, an analog or a mutant of a ligand, or an analog or a mutant of a receptor.

9. The method of claim 7 , wherein the visible signal is a fluorescent signal.

10. The method of claim 1 , wherein performing RPA comprises maintaining said reaction mixture at a temperature of at least 30° C., at least 35° C., or at least 40° C.

11. The method of claim 1 , wherein performing RPA comprises maintaining said reaction mixture at a temperature less than 45° C., less than 40° C., less than 35° C., or less than 30° C.

12. The method of claim 1 , wherein performing RPA comprises maintaining said reaction mixture at a temperature for a time period of approximately 5 minutes, approximately 15 minutes, approximately 30 minutes, or approximately 15-60 minutes.

13. The method of claim 5 wherein said first nucleic acid primer and said second nucleic acid primer are labeled with different detectable labels.

14. The method of claim 1 wherein said lateral flow strip comprises an antibody.

15. The method of claim 1 wherein said liquid sample comprises blood.

16. The method of claim 1 wherein said liquid sample comprises less than 100 copies of said target nucleic acid.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2020
From: ALERE SAN DIEGO INC.
To: ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Reel/Frame 054604/0936 →
CHANGE OF NAME Recorded Nov 19, 2020
From: ASM SCIENTIFIC, INC.
To: TWISTDX, INC.
Reel/Frame 054416/0420 →
MERGER Recorded Nov 19, 2020
From: TWISTDX, INC.
To: BIOSITE INCORPORATED
Reel/Frame 054416/0759 →
CHANGE OF NAME Recorded Nov 19, 2020
From: BIOSITE INCORPORATED
To: ALERE SAN DIEGO, INC.
Reel/Frame 054479/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2020
From: PIEPENBURG, OLAF; WILLIAMS, COLIN H.; ARMES, NIALL A.
To: ASM SCIENTIFIC, INC.
Reel/Frame 052255/0118 →
Continuity (7)
Division 14966352 · Dec 11, 2015
Continuation 14066334 · Oct 29, 2013
Continuation 13177007 · Jul 6, 2011
Division 11988825
Provisional Application 60702533 · Jul 25, 2005
Provisional Application 60728424 · Oct 18, 2005
Related Publication 20200095584A1 · Mar 26, 2020